361
Participants
Start Date
January 31, 2003
Study Completion Date
December 31, 2004
cabergoline
Cabergoline oral tablets: 0.5 mg daily on Days 1 to 3, 1.0 mg daily on Days 4 to 7, 1.5 mg daily on Days 8 to 10, and 2.0 mg daily on Days 11 to 14 and then administered as a stable dose for a further 4 weeks; at Week 6, dose could be increased to 3 mg daily if patient experienced insufficient efficacy without impairing adverse events
levodopa
Levodopa oral capsules: 25 mg twice daily on Days 1 to 3, 50 mg twice daily on Days 4 to 7, 100 mg twice daily on Days 8 to 14 and then administered as a stable dose for a further 4 weeks; at Week 6, dose could be increased to 150 mg twice daily if patient experienced insufficient efficacy without impairing adverse events
Pfizer Investigational Site, Basel
Pfizer Investigational Site, Innsbruck
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Bad Saarow
Pfizer Investigational Site, Neubrandenburg
Pfizer Investigational Site, Schwerin
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Quickborn
Pfizer Investigational Site, Oldenburg
Pfizer Investigational Site, Bremerhaven
Pfizer Investigational Site, Kassel
Pfizer Investigational Site, Schwalmstadt
Pfizer Investigational Site, Marburg
Pfizer Investigational Site, Göttingen
Pfizer Investigational Site, Göttingen
Pfizer Investigational Site, Düsseldorf
Pfizer Investigational Site, Mönchengladbach
Pfizer Investigational Site, Gelsenkirchen
Pfizer Investigational Site, Beckum
Pfizer Investigational Site, Bad Honnef
Pfizer Investigational Site, Aschaffenburg
Pfizer Investigational Site, Wiesbaden
Pfizer Investigational Site, Dillingen
Pfizer Investigational Site, Kaiserslautern
Pfizer Investigational Site, Stuttgart
Pfizer Investigational Site, Heilbronn
Pfizer Investigational Site, Karlsruhe
Pfizer Investigational Site, Tuttlingen
Pfizer Investigational Site, Altötting
Pfizer Investigational Site, Ulm
Pfizer Investigational Site, Regensburg
Pfizer Investigational Site, Vienna
Pfizer Investigational Site, Bochum
Pfizer Investigational Site, Duisburg
Pfizer Investigational Site, Jena
Pfizer Investigational Site, Karlsruhe
Pfizer Investigational Site, Köthen
Pfizer Investigational Site, Wolfsburg
Pfizer Investigational Site, Karlstad
Pfizer Investigational Site, Bern
Pfizer Investigational Site, Gera
Pfizer Investigational Site, Halle
Pfizer Investigational Site, Mittweida
Pfizer Investigational Site, Gothenburg
Pfizer Investigational Site, Linköping
Pfizer Investigational Site, Zurich
Lead Sponsor
Pfizer
INDUSTRY